Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pathogens, toxins, and autoantibodies is a collective term for diverse biological and chemical agents that induce disease states. Pathogens, including bacteria, viruses, and fungi, are infectious agents that invade host tissues and disrupt normal physiological processes (CDC, 2022). Toxins are harmful substances produced by organisms, such as botulinum toxin or ricin, which can cause acute poisoning or systemic damage (NIH, 2021). Autoantibodies are components of the immune system that lose self-tolerance and attack the host's own proteins or cells, leading to autoimmune disorders like systemic lupus erythematosus or myasthenia gravis (MedlinePlus, 2023). Because this grouping spans multiple biological kingdoms and chemical classes, it is not a single therapeutic target but a category of disease-causing entities. Treatments targeting these agents range from antimicrobial drugs and antitoxins to immunotherapies and extracorporeal removal techniques like plasmapheresis. These interventions aim to neutralize the agent, prevent its replication, or physically remove it from the patient's circulation to restore homeostasis (StatPearls, 2023).
Mechanisms include the inhibition of microbial cell wall or protein synthesis, the neutralization of toxins by specific antibodies, and the depletion of autoantibodies through B-cell targeting or extracorporeal removal (StatPearls, 2023).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogens, toxins, and autoantibodies.